Implementing Quantitative BCR-ABL P210 Testing in a Rural Healthcare Setting

被引：0
|
作者：
Haydon-Bradford, S. [1 ]
Gardner, M. [1 ]
Adamson, M. [1 ]
Hixson, T. [1 ]
Traufler, A. [1 ]
Figueroa, D. [1 ]
Erickson-Johnson, M. [1 ]
Starks, R. [1 ]
机构：
[1] Sanford Hlth, Sioux Falls, SD USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2023年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
G059
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] TYROSINE PHOSPHORYLATION OF P160 BCR BY P210 BCR-ABL
    LU, D
    LIU, JX
    CAMPBELL, M
    GUO, JQ
    HEISTERKAMP, N
    GROFFEN, J
    CANAANI, E
    ARLINGHAUS, R
    BLOOD, 1993, 82 (04) : 1257 - 1263
  • [2] Interaction of p62(dck) with p210(bcr-abl) and Bcr-Abl associated proteins.
    Bhat, A
    Johnson, K
    Oda, T
    Druker, BJ
    BLOOD, 1997, 90 (10) : 1089 - 1089
  • [3] Chronic myeloid leukemia with p210 BCR-ABL and monocytosis
    Dass, Jasmita
    Jain, Sonal
    Tyagi, Seema
    Sazawal, Sudha
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1380 - 1381
  • [4] Identification of transcriptional targets associated with the expression of p210 Bcr-Abl
    Hickey, FB
    Cotter, TG
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) : 369 - 383
  • [5] BACULOVIRUS EXPRESSION OF FUNCTIONAL P210 BCR-ABL ONCOGENE PRODUCT
    PENDERGAST, AM
    CLARK, R
    KAWASAKI, ES
    MCCORMICK, FP
    WITTE, ON
    ONCOGENE, 1989, 4 (06) : 759 - 766
  • [6] ANTISENSE INHIBITION OF P210 BCR-ABL IN CHRONIC MYELOID-LEUKEMIA
    VAERMAN, JL
    LEWALLE, P
    MARTIAT, P
    STEM CELLS, 1993, 11 : 89 - 95
  • [7] The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation
    Sahay, S.
    Pannucci, N. L.
    Mahon, G. M.
    Rodriguez, P. L.
    Megjugorac, N. J.
    Kostenko, E. V.
    Ozer, H. L.
    Whitehead, I. P.
    ONCOGENE, 2008, 27 (14) : 2064 - 2071
  • [8] P190 BCR-ABL mRNA is frequently expressed at a low level in p210 CML and p210 all
    vanRhee, F
    Hochhaus, A
    Lin, F
    Melo, JV
    Cross, NCP
    Goldman, JM
    BLOOD, 1995, 86 (10) : 2969 - 2969
  • [9] The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation
    S Sahay
    N L Pannucci
    G M Mahon
    P L Rodriguez
    N J Megjugorac
    E V Kostenko
    H L Ozer
    I P Whitehead
    Oncogene, 2008, 27 : 2064 - 2071
  • [10] Conventional Western blotting techniques will not reliably quantify p210 BCR-ABL - Response
    Copland, Mhairi
    Hamilton, Ashley
    Holyoake, Tessa L.
    BLOOD, 2007, 109 (03) : 1336 - 1336
12345